151 related articles for article (PubMed ID: 16442372)
1. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
Conen D; Zeller A; Pfisterer M; Martina B
Am J Cardiol; 2006 Jan; 97(2):249-52. PubMed ID: 16442372
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
Conen D; Dieterle T; Utech K; Rimner M; Martina B
Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
Ng LL; Pathik B; Loke IW; Squire IB; Davies JE
Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837
[TBL] [Abstract][Full Text] [Related]
6. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function.
Choi EY; Ha JW; Joung B; Ko YG; Choi D; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am J Cardiol; 2008 Feb; 101(3):364-9. PubMed ID: 18237601
[TBL] [Abstract][Full Text] [Related]
7. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
11. Substantial intraindividual variability of BNP concentrations in patients with hypertension.
Conen D; Pfisterer M; Martina B
J Hum Hypertens; 2006 Jun; 20(6):387-91. PubMed ID: 16484992
[TBL] [Abstract][Full Text] [Related]
12. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
[TBL] [Abstract][Full Text] [Related]
15. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
16. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
[TBL] [Abstract][Full Text] [Related]
17. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy.
Lukowicz TV; Fischer M; Hense HW; Döring A; Stritzke J; Riegger G; Schunkert H; Luchner A;
Eur J Heart Fail; 2005 Jun; 7(4):525-31. PubMed ID: 15921790
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
Fertin M; Hennache B; Hamon M; Ennezat PV; Biausque F; Elkohen M; Nugue O; Tricot O; Lamblin N; Pinet F; Bauters C
Am J Cardiol; 2010 Nov; 106(10):1410-6. PubMed ID: 21059429
[TBL] [Abstract][Full Text] [Related]
19. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
20. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
